Overview

Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia

Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
This study is to determine the efficacy (how well the drug works), safety, and any side effects of olanzapine compared to placebo in the treatment of schizophrenia in adolescents. Both the potential benefits and side effects of olanzapine will be evaluated throughout this trial.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Olanzapine